Skip to content
Search AI Powered

Latest Stories

In a huge vote of confidence for sector, Govt pledges £645m to expand community pharmacy services

As part of a new blueprint for primary care, the government today (May 9) announced an investment of £645 million over two years to expand community pharmacy services in England.

In a statement, NHS England said: "For the first time ever, patients who need prescription medication will be able to get it directly from a pharmacy, without a GP appointment, for seven common conditions including earache, sore throat, or urinary tract infections."


Prime minister Rishi Sunak hopes that the measures will help end the "all-too stressful wait on the end of the phone for patients" by freeing up 15 million slots at doctors’ surgeries over the next two years.

"We will end the 8am rush and expand the services offered by pharmacies, meaning patients can get their medication quickly and easily," he said

Almost half a million women will no longer need to speak to a practice nurse or GP to access oral contraception and will instead be able to pop into their local pharmacy for it, according to the government announcement.

Blood checks for people suffering from moderate risk of heart attack or stroke conducted in community pharmacies will more than double from 900,000 last year to 2.5 million next year.

NHS chief executive Amanda Pritchard said the "ambitious package" would help transform how care is provided within the health service "with pharmacies playing a central role in managing the nation’s health including providing lifesaving checks and medication for common conditions for the first time.

"This blueprint will help us to free up millions of appointments for those who need them most, as well as supporting staff so that they can do less admin and spend more time with patients."

A huge vote of confidence

Janet Morrison, Pharmaceutical Services Negotiating Committee CEO, called the plan "a very welcome step towards putting pharmacies even more at the heart of primary care and prevention."

She said: "This investment in community pharmacy and its future – the biggest investment in pharmacies for many years – is a huge vote of confidence from government, the NHS and from ministers."

Morrison added: "We hope that a fully-funded common conditions service and additional investment in the two existing services will help to give us a platform from which to build an ambitious future for pharmacies in the communities they serve.

"It is now clear that ministers recognize the value that pharmacies can offer and the services we can provide if we are put on a sustainable footing, and we will be looking to build on that positivity through our ongoing vision and strategy work. A financially supported community pharmacy sector can do so much more."

Momentous development

NPA chief executive Mark Lyonette welcomed the commitment "to invest in a pharmacy-based common ailments service," but noted that his association would like to look carefully at the details of the plan.

"But from the initial information this appears to be a momentous development, which has the potential to radically change the outlook for our sector, as well as benefiting patients,” he said.

Dr Leyla Hannbeck, CEO of the Association of Independent Multiple Pharmacies, said that plan recognised the important role that the sector could play in improving patient access to care.

"Our communities know us and trust us and for some time, we’ve been arguing that we can be a key solution to many of the challenges facing the NHS and asking the government to put us at the heart of their thinking.

"Measures to facilitate patient care with less cumbersome and time-consuming bureaucratic burden will be welcome news by pharmacy teams the length and breath of the country.”

Real game-changer

Malcolm Harrison, the Chief Executive of the Company Chemists Association, said: "We have long been calling for the NHS to allow community pharmacy to play a leading role in urgent care.

"The access pharmacies offer is essential to tackling health inequalities and meeting a growing patient need. We encourage NHS England to be ambitious in their plans and take full advantage of this opportunity.”

Calling the plan a "real game-changer" for patients, RPS England chair Thorrun Govind echoed similar sentiments as Harrison.

"These plans will help to reduce health inequalities, especially in deprived areas where pharmacies are at the heart of their communities and trusted by patients," she said.

“Providing treatment to help prevent common conditions from becoming worse and requiring more complex treatment later on is better for patients and also cost-effective. Patients can expect to receive trusted advice from pharmacists in their local pharmacy."

Shilpa Shah, CEO of North East London LPC, said: "This is step in the right direction and a win for Community Pharmacy. We look forward to seeing the detail once this has all been finalised. This funding shows that the government value community pharmacy and can visualise a clear place for us within primary care."

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less